Bayer Canada

A Life Science Company

read more
A Life Science Company

Explore Your Topic

Latest News

Share Price/Index

Local News

March 11, 2019

New Single-dose Treatment for Canine Otitis Externa Launches in Canada

Claro® provides veterinarians with an effective first-line therapy that eliminates the need for in-home application by pet owners Read more
March 06, 2019

Bayer Inc. investing $500,000 in STEM education for Canadian youth through Let’s Talk Science

Read more
February 21, 2019

Bayer’s darolutamide plus androgen deprivation therapy (ADT) significantly extends metastasis-free survival by 22 months, with a favourable safety profile compared to placebo plus ADT in non-metastatic castration-resistant prostate cancer

Darolutamide significantly improved median metastasis-free survival (MFS) by 22 months (40.4 months with darolutamide plus androgen deprivation therapy (ADT) versus 18.4 months for placebo plus ADT / Positive trend in overall survival with a 29% reduction in risk of death at interim analysis (P=0.045) / Incidence of treatment-emergent adverse events was similar between darolutamide plus ADT and placebo plus ADT/ Health-related quality of life was maintained/ First results from the Phase III ARAMIS trial with the androgen receptor antagonist darolutamide were presented in an oral presentation at American Society of Clinical Oncology Genitourinary Cancers Symposium (ASCO GU) 2019 and simultaneously published in The New England Journal of Medicine Read more
Bayer News Overview

Global News

February 27, 2019

Bayer increases sales and earnings – leader in agriculture after acquisition

Read more

Advance Your Career

Jobs at Bayer Canada

  • Interested in working for us? See if there are job openings in Canada.

  • read more

Our Businesses

We research, develop and market innovative products that improve the health of people, plants and animals. Our business comprises three core divisions and two business units. Learn more about it here.

Last updated: January 02, 2019